AzTrials
AzTrials

Bone ResorptionNCT06049823

Alveolar Ridge Preservation With Different Grafting Strategies

A study testing Alveolar ridge preservation in people with Bone Resorption, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study was to compare the half-packed grafts that are covered with either a collagen or a nonresorbable membrane to the conventional alveolar ridge preservation procedures involving full-packed grafts and collagen membrane. Read more about this study

Who is it for?
Ages 24 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Bone Resorption
What is being tested?
Alveolar ridge preservation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTaiwan
Study dates
10 May 2021to 12 Jul 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ≥ 20 years old
  • presence of one or more hopeless teeth requiring extraction and subsequent implant placement due to reasons such as crack tooth, vertical root fracture, endodontic failure, unrestorable caries and severe periodontitis
  • the extraction socket should have more than two walls for ARP, which includes type I-II sockets (Palatal/ lingual defects were also included)
  • participants should have a stable periodontal condition or history of periodontitis that is well-controlled with good oral hygiene. The pocket depth of the adjacent tooth around the socket should be less than 3 mm as assessed with a periodontal probe (Hu-Friedy, Chicago, IL, USA).

Who cannot join

  • heavy smokers consuming more than half pack of cigarettes daily
  • women who were pregnant, lactating, or planning to be pregnant
  • history of psychiatric disorders
  • uncontrolled and complicated medical conditions that might hinder wound healing or bone metabolism, including poorly controlled diabetes, autoimmune disorders, receiving current radiotherapy in the head and neck regions, taking bisphosphonate and other antiresorptive agents.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Taipei Chang Gung Memorial hospital

    Taipei, 105

Other trials in Taiwan

About this study

Official title: Comparison of Half- and Full-Grafting Alveolar Ridge Preservation With Different Sealing Materials: A Three-arm Randomized Clinical Trial

The aim of the present study was to compare the half-packed grafts that are covered with either a collagen or a nonresorbable membrane to the conventional alveolar ridge preservation procedures involving full-packed grafts and collagen membrane. The primary purpose was to evaluate the bone dimensional changes between the groups, and the secondary objective was to assess the potential contributing factors to clinical, radiographic and implant-related outcomes under different alveolar ridge preservation procedures.

Read the detailed description

Regarding different surgical approaches in alveolar ridge preservation, limited studies directly compare collagen and non-resorbable membrane, and the comparison between half- and full- grafting strategy in clinical and radiographic outcomes was still lacking. The comparable effect of dimensional preservation between groups was shown except for more radiographic bone gain in full-grafting group. Contributing factors, including thin bone thickness , vertical root fracture related sockets, non-molar sites and large BPD might attenuate the effect of ARP. At implant placement, similar results in bone quality and keratinized mucosal width was found in all groups, while thicker vertical mucosal thickness was obtained when using nonresorbable membrane. All surgical modalities in alveolar ridge preservation yield stable peri-implant health 1 year after implant placement.

Conditions
Bone Resorption
Being tested
Alveolar ridge preservation
Keywords
alveolar ridge preservation, sealing material, resorbable membrane, non-resorbable membrane, dental implants
Medical subject headings
Bone Resorption

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Alveolar ridge preservationProcedure or surgery

    Different grafting strategy of alveolar ridge preservation with different sealing materials

Study groups in NCT06049823
Study groupRoleWhat they receive
Test1Experimentalhalf- (bottom 50% of socket filled with gelatin sponge and the top 50% of the socket filled with deproteinized bovine bone mineral mixed with collagen (DBBM-C)) then covered with a collagen membrane in tooth sockets
Receives: Procedure: Alveolar ridge preservation
Test2Experimentalhalf- (bottom 50% of socket filled with gelatin sponge and the top 50% of the socket filled with deproteinized bovine bone mineral mixed with collagen (DBBM-C)) then covered with a nonresorbable membrane in tooth sockets
Receives: Procedure: Alveolar ridge preservation
ControlExperimentalfull-grafting (DBBM-C+ Collagen membrane) in tooth sockets
Receives: Procedure: Alveolar ridge preservation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone dimensional changes between the groups

    Based on CBCT images, horizontal measurements by using AVIZO software (version 7.0, FEI). The measurements were repeated twice at a 2-week interval, and mean values were used for the final analysis (width or height in millimeters, mm):

    • Buccal bone plate thickness (BT) at 1 mm, 3mm, 5mm apical to the crest
    • Horizontal ridge width (HRW) at 1 at 1 mm, 3mm, 5mm apical to the crest
    • The change of HRW at 1, 3, 5 mm apical to crest (T2-T1).

    Vertical measurements in cross-sectional images:

    • Buccal bone height (BH)(mm)
    • Palatal/lingual bone height (PH)(mm)
    • The discrepancy between buccal and palatal/lingual height.(mm)
    • Midcrestal height (Mid-H)(mm)
    • The change of BH, PH, and Mid-H between immediate post-operative and 6 months later. (T2-T1)(mm).

    Measured: 6-month healing period after alveolar ridge preservation

Secondary outcomes (1)
  1. Clinical and implant related outcomes

    Other clinical and implant-related parameters with descriptions:

    • Demographic data
    • Keratinized mucosal width (KMW)(mm)
    • Vertical mucosal thickness (VMT): measured from the mucosal profile to the crest of the ridge using a periodontal probe after buccal full-thickness flap elevation (Hu-Friedy, Chicago, IL, USA)(mm)
    • Bone density: Lekholm and Zarb's classification as types 1, 2, 3, or 4
    • Insertion torque: recorded once the implant was placed at the anticipated level with primary stability (NCM)
    • Marginal bone level change(mm) Based on the results of the normality tests, one-way ANOVA followed by the Tukey HSD or Kruskal-Wallis test with post hoc Dunn's test was performed for intergroup comparisons. The Chi-square association test (X2) was used to compare categorical variables between groups. Univariate linear regression methods were performed to investigate the factors to the changes of ridge width and height.

    Measured: 6-month healing period after alveolar ridge preservation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Sep 2023
  2. Study start10 May 2021
  3. Primary completion7 Mar 2023
  4. Study completion12 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06049823
Sponsor's protocol ID
Chang Gung MH
Status last verified
Sep 2023
First submitted
11 Sep 2023
Last updated
22 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Raw data were generated at Taipei Chang Gung memorial hospital. Derived data supporting the findings of this study are available from the corresponding author(CYL) on request.

Publications

  • Lin CY, Chiu MY, Kuo PY, Wang HL. Half- and full-grafting alveolar ridge preservation with different sealing materials: A three-arm randomized clinical trial. Clin Implant Dent Relat Res. 2024 Jun;26(3):651-662. doi: 10.1111/cid.13327. Epub 2024 Apr 18.

    PubMed 38638057

Questions about this trial

What is this clinical trial studying?

A study testing Alveolar ridge preservation in people with Bone Resorption, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone dimensional changes between the groups (time frame: 6-month healing period after alveolar ridge preservation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06049823, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in